Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase

Emerging evidence suggests that dipeptidyl peptidase-4 (DPP-4) inhibitors, including sitagliptin, exert favourable effects on the vascular endothelium. DPP-4 inhibitors suppress the degradation of glucagon-like peptide-1 (GLP-1), which has been reported to enhance nitric oxide (NO) production. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: TANG, SONG-TAO, SU, HUAN, ZHANG, QIU, TANG, HAI-QIN, WANG, CHANG-JIANG, ZHOU, QING, WEI, WEI, ZHU, HUA-QING, WANG, YUAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866950/
https://www.ncbi.nlm.nih.gov/pubmed/27122056
http://dx.doi.org/10.3892/ijmm.2016.2578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866950/
https://www.ncbi.nlm.nih.gov/pubmed/27122056
http://dx.doi.org/10.3892/ijmm.2016.2578

Ejemplares similares